In addition, IFN-γ may affect the effectiveness of anti-PD-1 antibody therapy, particularly as it can induce the expression of PD-1 ligands on the surface of some tumour cells, including those in ovarian cancer, potentially promoting tumour progression [29]. Here, IFNG is linked to neoplasm.